Advertisement

Latest Update

Medical

New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results

Disease

Long-Term Antihypertensive Drugs Hurt Liver And Kidneys? Doctors: No Medication Is More Risky!

Healthy

The rational use of notebook computers can be started from three aspects

Apparatus

Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib

Hospital

Munich University Hospital

The Most Important Task For Diabetics Is To Prevent Coronary Heart Disease
The World's First Gene Therapy For Haemophilia Approved! A Single Infusion That Greatly Reduces Patient Bleeding!
FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

Medical see latest

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!

For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise

New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away!
Hyperthyroidism and pregnancy are not "irreconcilable"
Study Shows That a Blood Pressure Drug Combined With Radiotherapy Improves Outcomes In Locally Advanced Pancreatic Cancer
Speaking of medical history should focus on the key points

Disease see latest

Does a Full Stomach Really Hurt Your Brain?

New research suggests that in humans and rodents, obesity is indeed associated with damage to brain areas responsible for weight control

Don't treat allergic rhinitis as a cold
Can People With HIV Have Healthy Babies Too?
How to prevent cervical cancer? Let's see what gynecologists say

Healthy see latest

What Do Women Take To Nourish Their Blood When They Are Anemic?

Four Measures To Combat Bronchitis

How can we prevent a heart attack when it's cold?

Apparatus see latest

New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu

The FDA granted priority review status to Enhertu (DS-8201) for the treatment of patients with HR-positive, low HER2-expressing breast cancer, and Enhertu has enabled these patients to remain disease-free for an average of 10.1 months, with an average overall survival time of nearly two years. A decision on approval is expected to be made in the fourth quarter of this year.

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For

The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma!

The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma!
Germany Develops Faster, Cheaper New Crown Pcr Assay
Airway Announces First Patient To Receive Dose In Bpd Trial
Pre-Operative Immunotherapy And More Than Half Of The Tumours In This Type Of Skin Cancer Disappear Completely!
Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer!

Hospital see latest

Singapore General Hospital - Top 10 Best Hospitals in the World
UniversityClinic Hamburg-Eppendorf，UKE
Rush University Medical Center
University of Pittsburgh Medical Center，UPMC
Memorial Sloan Kettering Cancer Centre, USA
New York Presbyterian University Hospital of Columbia and Cornell

Shizuoka National Epilepsy Centre, Japan

RECENT ARTICLES

New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results

The rational use of notebook computers can be started from three aspects
Munich University Hospital
Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib